Purchase Order W81K0221P0072
- Not listed
- This firm fixed-price purchase order was awarded by the Department of the Army Medical Command to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and reagents. The $144,074.38 contract is for Illumina RNA prep with enrichment supplies to support the MiSeq system used at the Tripler Army Medical Center in Hawaii. The award was made on a sole-source basis without a set-aside, citing Illumina as the only responsible source for the proprietary sequencing technology....
- This firm fixed-price purchase order was awarded by the Defense Health Agency to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the procurement of Urinary Pathogen ID/AMR Enrichment Kits. The $61,848.39 contract has a period of performance through September 30, 2024 and will support the use of government-owned Illumina MiSeq sequencing instruments at Tripler Army Medical Center in Hawaii. The award was made on a sole source basis under the simplified acquisition...
- This firm fixed-price purchase order, valued at $2,881,079.36, was awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing products and services. The contract supports genomic sequencing and analysis needs, with Illumina providing a range of sequencing systems, reagents, and bioinformatics products. This award does not have a set-aside designation. Illumina has previously received prime contract and subcontract awards from various federal...
- The Department of the Army Medical Command awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis solutions, for the provision of a NextSeq 2000 Sequencing System. The total potential value of the award is $236,845.00. This requirement was solicited on a sole source basis due to Illumina's proprietary technology and the system's unique capabilities needed to support the U.S. Army Medical Research Institute of Infectious Diseases'...
- This is a firm fixed price delivery order contract valued at $242,110.64 awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of Illumina reagents to support the agency's sequencing and genomic analysis needs, without any set-aside designation. Illumina has a history of supporting federal agencies like the NIH, CDC, USDA, and VA with its sequencing systems and related products and...
- This is a firm fixed price purchase order awarded by the Department of the Army Medical Command to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the provision of ILLUMINA REAGENTS FOR USACEHR. The $429,892.20 contract has a completion date of December 4, 2017. Illumina has previously provided sequencing systems, reagents, and related services to support genomic research and diagnostics for various federal agencies. This award does not have a set-aside...
- This firm fixed-price purchase order contract was awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical tools. The $282,150.00 contract provides for the delivery of a MiSeq diagnostic sequencing system to support research and analysis at the U.S. Army's Fort Detrick facility in Maryland. Illumina has previously provided sequencing platforms and related services to federal agencies including the...
- This is a firm fixed price BPA call contract awarded by the Department of the Army Medical Command to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The $122,547.54 contract is for the delivery of Illumina sequencing systems and associated supplies, such as reagents, consumables, and support services, to be used at the Fort Detrick facility in Maryland. Illumina has previously received awards from other federal agencies, including the NIH, CDC, USDA, and...
- This is a firm fixed price delivery order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract has a ceiling value of $473,964.67 and is for the provision of various Illumina reagents, with a period of performance through October 28, 2015. This appears to be part of a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy Bureau of...
- This is a firm fixed price BPA call contract awarded by the Department of the Army Medical Command to Illumina, Inc., a manufacturer of DNA sequencing and genomic analysis systems. The $181,119.66 contract is for the provision of various Illumina DNA sequencing instruments, reagents, and related support services to be performed at Fort Detrick, MD. Illumina has a history of providing similar sequencing equipment and services to other federal agencies such as the NIH, CDC, USDA, and VA to support...
The Department of the Army Medical Command awarded a $247,627.76 firm fixed-price purchase order to Illumina, Inc., a for-profit manufacturing organization, for Illumina RNA Prep with Enrichment products and services. The contract does not have a set-aside designation. This award was made without full and open competition under the sole-source authority of FAR 13.106-1(b)(1)(i) based on Illumina's proprietary sequencing technology and status as the sole manufacturer. Illumina has a history of providing sequencing instruments, reagents, and bioinformatics to federal agencies like the NIH, CDC, and VA to support genomic research and diagnostics. This award will supply equipment and consumables to the Tripler Army Medical Center in Hawaii to support nucleic acid sequencing needs.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
DNA Sequencing Supplies | W81K0221Q0068 | Department of the Army Medical Command | Pre-Solicitation 1/1 | 3/24/21, 7:25 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $247.6k | 5/7/21 |